Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$980M |
| 2 |
Humana
HUM
|
+$637M |
| 3 |
Apple
AAPL
|
+$620M |
| 4 |
Home Depot
HD
|
+$541M |
| 5 |
Microsoft
MSFT
|
+$539M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$770M |
| 2 |
McDonald's
MCD
|
+$654M |
| 3 |
Cigna
CI
|
+$498M |
| 4 |
Digital Realty Trust
DLR
|
+$430M |
| 5 |
Amazon
AMZN
|
+$429M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.91% |
| 2 | Healthcare | 3.33% |
| 3 | Consumer Discretionary | 2% |
| 4 | Industrials | 1.79% |
| 5 | Financials | 1.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6201
PUT
Arhaus
ARHS
$1.35B
| $1.14M | ﹤0.01% |
123,100
+39,200
| +47% | +$411K |
|
6202
PUT
Transmedics
TMDX
$3.06B
| $1.14M | ﹤0.01% |
20,900
+6,300
| +43% | +$454K |
|
6203
CALL
Atara Biotherapeutics
ATRA
$83.9M
| $1.14M | ﹤0.01% |
30,924
+192
| +0.6% | +$8.55K |
|
6204
PUT
Boise Cascade
BCC
$2.86B
| $1.14M | ﹤0.01% |
11,100
-1,600
| -13% | -$165K |
|
|
WHWK
6205
Whitehawk Therapeutics
WHWK
$265M
| $1.14M | ﹤0.01% |
236,266
-22,627
| -9% | -$132K |
|
6206
Oportun Financial
OPRT
$346M
| $1.14M | ﹤0.01% |
158,376
-30,482
| -16% | -$201K |
|
6207
PUT
Walker & Dunlop
WD
$1.4B
| $1.14M | ﹤0.01% |
15,400
+13,000
| +542% | +$1.1M |
|
6208
Timothy Plan High Dividend Stock ETF
TPHD
$372M
| $1.14M | ﹤0.01% |
37,336
+7,122
| +24% | +$227K |
|
6209
CALL
Suburban Propane Partners
SPH
$1.17B
| $1.14M | ﹤0.01% |
71,200
+35,300
| +98% | +$521K |
|
6210
Goldman Sachs Hedge Industry VIP ETF
GVIP
$589M
| $1.14M | ﹤0.01% |
13,359
-794
| -6% | -$69.3K |
|
6211
Hercules Capital
HTGC
$3.1B
| $1.14M | ﹤0.01% |
69,568
-196,084
| -74% | -$3.21M |
|
6212
Avantis International Small Cap Equity ETF
AVDS
$337M
| $1.14M | ﹤0.01% |
+24,290
| New | +$1.18M |
|
|
BRSP
6213
BrightSpire Capital
BRSP
$615M
| $1.14M | ﹤0.01% |
182,093
+13,075
| +8% | +$89.5K |
|
6214
Fabrinet
FN
$21.4B
| $1.14M | ﹤0.01% |
6,832
-58,557
| -90% | -$8.12M |
|
6215
WBI BullBear Value 3000 ETF
WBIF
$23.4M
| $1.14M | ﹤0.01% |
42,532
+17,538
| +70% | +$494K |
|
6216
Global X SuperDividend ETF
SDIV
$1.22B
| $1.14M | ﹤0.01% |
51,938
-39,139
| -43% | -$883K |
|
6217
PUT
Surgery Partners
SGRY
$1.88B
| $1.14M | ﹤0.01% |
38,900
+13,200
| +51% | +$475K |
|
6218
PUT
UFP Industries
UFPI
$4.87B
| $1.14M | ﹤0.01% |
11,100
+8,500
| +327% | +$859K |
|
6219
CALL
Symbotic
SYM
$5.5B
| $1.14M | ﹤0.01% |
34,000
+12,600
| +59% | +$518K |
|
|
WNS
6220
CALL
DELISTED
WNS Holdings
WNS
| $1.14M | ﹤0.01% |
16,600
+9,800
| +144% | +$662K |
|
6221
CALL
Rayonier
RYN
$6.44B
| $1.14M | ﹤0.01% |
43,979
+15,762
| +56% | +$440K |
|
6222
JPMorgan US Quality Factor ETF
JQUA
$8.61B
| $1.14M | ﹤0.01% |
+26,237
| New | +$1.17M |
|
6223
CALL
Vanguard Morningstar Large-Cap ETF
VV
$54.5B
| $1.14M | ﹤0.01% |
5,800
-6,300
| -52% | -$1.28M |
|
6224
CALL
M/I Homes
MHO
$3.82B
| $1.13M | ﹤0.01% |
13,500
-125,600
| -90% | -$11.6M |
|
6225
Fidelity Limited Term Bond ETF
FLTB
$435M
| $1.13M | ﹤0.01% |
23,714
-8,039
| -25% | -$386K |
|
Similar funds
Citadel Advisors's Q3 2023 Portfolio in Review
As of Q3 2023, Citadel Advisors held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Citadel Advisors's Q3 2023 filing shows 1,406 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.
By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Citadel Advisors's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
- Citadel Advisors added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
- Citadel Advisors's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
- Citadel Advisors fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
- Citadel Advisors's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
- Citadel Advisors opened 1,406 new positions and closed 1,460 in Q3 2023.
- Citadel Advisors's portfolio value fell 3.6% quarter-over-quarter to $467B.
Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.